Eligibility criteria
Condition
Pain
Sex
Females and Males
Age
18 + years
Inclusion criteria
Show details
- Patients must have met the patient selection criteria for the preceding double-blind
Protocol A6061026 and have completed the 16-week trial.
- Patients at screening must have a score of >/=40mm on the pain visual analogue scale.
Exclusion criteria
Show details
- Serious adverse event during the preceding double-blind Protocol A6061026 that was
determined to be related to the trial medication by the Investigator.
- Patient treatment compliance was less than 80% in the preceding double-blind Protocol
A6061026.